4-(2-Aminoethyl)benzenesulfonamide

We are 4-(2-Aminoethyl)benzenesulfonamide CAS:35303-76-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 4-(2-Aminoethyl)benzenesulfonamide
CAS.NO:35303-76-5
Synonyms:
4-(2-aminoethyl)-benzenesulphonamide
4-(2-Aminoethyl)Benzenesulfonamide
2-(4-sulfamoyl-phenyl)-ethylamine
4-(2-Ethylamino) Benzene Sulfonamide
4-Aminoethylbenzenesulfonamide

Molecular Formula:C8H12N2O2S
Molecular Weight:200.25800

Physical and Chemical Properties:
Density: 1.293g / cm3
Boiling point: 387.4ºC at 760mmHg
Melting point: 150-152 ° C (lit.)
Flash point: 188.1ºC
Refractive index: 1.587

Specification:
Appearance:White or off white powder
Purity:≥98%
Loss on drying: ≤0.5%
Residue on ignition: ≤0.12%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Glipizide CAS:29094-61-9

Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.1001401-62-2 The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.146862-02-4 The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.4-Methyl-2-pyridinecarbonitrile The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.